Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

enVVeno Medical Corp (HJLI) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 8-K Quarterly results
08/24/2023 EFFECT Form EFFECT - Notice of Effectiveness:
08/14/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
07/31/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
07/31/2023 10-Q Quarterly Report for the period ended June 30, 2023
05/26/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
05/05/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
03/02/2023 10-K Annual Report for the period ended December 31, 2022
02/14/2023 SC 13G/A PERCEPTIVE ADVISORS LLC reports a 9.9% stake in enVVeno Medical Corporation
12/06/2022 8-K Quarterly results
11/01/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
10/27/2022 10-Q Quarterly Report for the period ended September 30, 2022
08/03/2022 10-Q Quarterly Report for the period ended June 30, 2022
05/16/2022 UPLOAD Form UPLOAD - SEC-generated letter:
05/11/2022 10-Q/A Quarterly Report for the period ended March 31, 2022 [amend]
05/11/2022 10-K/A Annual Report for the period ended December 31, 2021 [amend]
05/11/2022 CORRESP Form CORRESP - Correspondence:
05/06/2022 UPLOAD Form UPLOAD - SEC-generated letter:
04/29/2022 10-Q Quarterly Report for the period ended March 31, 2022
04/18/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/28/2022 10-K Annual Report for the period ended December 31, 2021
02/14/2022 SC 13G/A PERCEPTIVE ADVISORS LLC reports a 9.9% stake in enVVeno Medical Corporation
02/14/2022 SC 13G/A CVI Investments, Inc. reports a 2.9% stake in enVVeno Medical Corporation
02/11/2022 SC 13G/A INTRACOASTAL CAPITAL, LLC reports a 4.4% stake in enVVeno Medical Corporation
01/19/2022 SC 13G/A Empery Asset Management, LP reports a 4.7% stake in enVVeno Medical Corporation
12/03/2021 8-K/A Quarterly results
12/01/2021 8-K Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure  Interactive Data
10/01/2021 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "CERTIFICATE OF AMENDMENT TO THE FIFTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF HANCOCK JAFFE LABORATORIES, INC. The undersigned, for the purposes of amending the Fifth Amended and Restated Certificate of Incorporation of Hancock Jaffe Laboratories, Inc. , a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware , does hereby certify that: FIRST : The Board of Directors of the Corporation duly adopted in accordance with Section 141 of the DCGL on September 20, 2021, a resolution proposing and declaring advisable the following amendment to Article FIRST of the Certificate of Incorporation of said Corporation: FIRST: The name of the corporation is “enVVeno Medical Corporation” . SECOND : The aforesaid amendment was duly adopt..."
09/22/2021 8-K Quarterly results
09/17/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
09/08/2021 8-K Quarterly results
09/08/2021 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/12/2021 8-K Quarterly results
08/12/2021 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy